Drug Trial Radar · NCT07357610
An Open-Label Drug Interaction Clinical Study to Evaluate Itraconazole, Rifampin, Midazolam and SIM0270 in Chinese Healthy Adult Participants
Last checked: Nov 19, 2026Latest source record: Jan 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
60
Planned (sponsor's estimate)
Start
Jan 5, 2026
Primary completion
Oct 30, 2026
Study completion Oct 30, 2026
Sponsor
- Lead sponsor
- Jiangsu Simcere Pharmaceutical Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Jan 22, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Other
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 55 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study is an open-label, fixed-sequence, two-period Phase 1 clinical trial in healthy adult Chinese participants with a total of 3 cohorts, 16-20 healthy adult Chinese participants are planned to be enrolled in each cohort.
Conditions
- Healthy Adult Participants
Interventions
SIM0270Drug
oral
itraconazoleDrug
oral
RifampinDrug
oral
midazolamDrug
oral
Primary outcomes
What the sponsor says the trial is designed to measure.
- Maximum observed concentration (Cmax) of SIM0270Time frame: Day 1-Day 13, Day 16-Day 30
- Area under concentration curve from time 0 to the last quantifiable concentration (AUC0-t) of SIM0270Time frame: Day 1-Day 13, Day 16-Day 30
- Area under concentration-time curve from time 0 to infinity (AUC0-∞) of SIM0270Time frame: Day 1-Day 13, Day 16-Day 30
- Area under concentration-time curve from time 0 to tau (AUC0-tau) of SIM0270Time frame: Day 1-Day 13, Day 16-Day 30
- Terminal half-life(t1/2)of SIM0270Time frame: Day 1-Day 13, Day 16-Day 30
- Maximum observed concentration (Cmax) of SIM0270Time frame: Day 1-Day 13, Day 20-Day 32
- Area under concentration curve from time 0 to the last quantifiable concentration (AUC0-t) of SIM0270Time frame: Day 1-Day 13, Day 20-Day 32
- Area under concentration-time curve from time 0 to infinity (AUC0-∞) of SIM0270Time frame: Day 1-Day 13, Day 20-Day 32
- Terminal half-life(t1/2)of SIM0270Time frame: Day 1-Day 13, Day 20-Day 32
- Maximum observed concentration (Cmax) of midazolamTime frame: Day 1-Day 2, Day 11-Day 13
- Area under concentration curve from time 0 to the last quantifiable concentration (AUC0-t) of MidazolamTime frame: Day 1-Day 2, Day 11-Day 13
- Area under concentration-time curve from time 0 to infinity (AUC0-∞) of MidazolamTime frame: Day 1-Day 2, Day 11-Day 13
- Terminal half-life(t1/2)of midazolamTime frame: Day 1-Day 2, Day 11-Day 13
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Shandong University of Qilu Hospital
Jinan, Shandong, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.